Barbara D. Wamil

459 citations
16 papers · 279 indexed · h-index 11
Topics
Cell Adhesion Molecules Research (5 papers)Cancer Research and Treatments (3 papers)Angiogenesis and VEGF in Cancer (3 papers)
Partner nations
United StatesItalySweden

In The Last Decade

Barbara D. Wamil

16 papers receiving 269 citations

Peers

Barbara D. Wamil
Comparison fields: 5 of 58
  • Molecular Biology 107
  • Oncology 94
  • Cancer Research 91
  • Pathology and Forensic Medicine 58
  • Genetics 47
Replace Frédéric Kesteloot with:
Frédéric Kesteloot Belgium
Ryoji Kitamura Japan
Anne Gompf Germany
Cathleen Rich United States
Marko Ständer Germany
David F. Chang United States
Masayo Sakaki‐Yumoto Japan
Adrienne M. Dorrance United States
Yasutaka Tokuda Japan
Mizuo HASHIMOTO Japan
Barbara D. Wamil relative to Frédéric Kesteloot Belgium Frédéric Kesteloot's profile →
Citations per field
00.5×4.1×
Frédéric Kesteloot · 1×
Citations per year

Countries citing papers authored by Barbara D. Wamil

Since Specialization
Citations

This map shows the geographic impact of Barbara D. Wamil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara D. Wamil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara D. Wamil more than expected).

Fields of papers citing papers by Barbara D. Wamil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara D. Wamil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara D. Wamil. The network helps show where Barbara D. Wamil may publish in the future.

Co-authorship network of co-authors of Barbara D. Wamil

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara D. Wamil. A scholar is included among the top collaborators of Barbara D. Wamil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara D. Wamil. Barbara D. Wamil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 3
2 68
3 4
4 5
5 10
6 17
7
Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis.
10
8 11
9
CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.
13
10 11
11 50
12
Phase I study of the antineovascularization drug CM101.
35
13 5
14 21
15 11
16 5

About Barbara D. Wamil

Barbara D. Wamil is a scholar working on Immunology and Allergy, Cancer Research and Biotechnology, having authored 16 papers that have together received 279 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (5 papers), Cancer Research and Treatments (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (91 citations), Immunology and Allergy (33 citations) and Developmental Neuroscience (15 citations). Barbara D. Wamil has collaborated with scholars based in United States, Italy and Sweden. Frequent co-authors include Carl G. Hellerqvist, Artur W. Wamil, Gary B. Thurman, Heping Yan, Clint E. Carter, Håkan Sundell, Russell F. DeVore, David L. Page, W. Jonat and Kathleen I. Pritchard. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026